LIHSIEN MARX: Open Payments
NPI 1215784806 · LITTLE ROCK, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$240 in 11 payments from 6 companies in 2025. Trend: 2023 $0 · 2024 $43 · 2025 $240
Food & beverage: $240
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 4 | $74 |
| TG Therapeutics, Inc. | 2 | $59 |
| ABBVIE INC. | 2 | $41 |
| GENZYME CORPORATION | 1 | $30 |
| UCB, Inc. | 1 | $19 |
| PFIZER INC. | 1 | $15 |
Products named: KESIMPTA, BRIUMVI, QULIPTA, Nayzilam, ELIQUIS, UBRELVY.
Industry payments across AR — which companies pay providers there.
